Aridis Pharmaceuticals Inc.

01/27/2022 | Press release | Distributed by Public on 01/27/2022 05:48

Aridis Pharmaceuticals Receives Funding to Evaluate Inhaled Monoclonal Antibodies to Block Influenza and SARS-CoV-2 Transmission